Reunion Neuroscience Inc.
REUN · NASDAQ
3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
|---|---|---|---|---|
| Market Cap | $10,860 | $96,757 | $186,757 | $20,934 |
| - Cash | $27,200 | $63,720 | $38,469 | $9,591 |
| + Debt | $3,368 | $29,052 | $7,497 | $1,541 |
| Enterprise Value | -$12,972 | $62,089 | $155,785 | $12,884 |
| Revenue | $0 | $4,860 | $961 | $1 |
| % Growth | -100% | 405.8% | 95,989.5% | – |
| Gross Profit | $0 | -$4,290 | -$583 | -$8 |
| % Margin | – | -88.3% | -60.7% | -840.3% |
| EBITDA | -$17,147 | -$58,731 | -$21,420 | -$6,940 |
| % Margin | – | -1,208.4% | -2,229.2% | -693,999.9% |
| Net Income | -$66,221 | -$55,787 | -$23,421 | -$2,651 |
| % Margin | – | -1,147.9% | -2,437.4% | -265,088.6% |
| EPS Diluted | -5.69 | -4.83 | -3.54 | -0.35 |
| % Growth | -17.8% | -36.4% | -911.4% | – |
| Operating Cash Flow | -$27,917 | -$44,262 | -$16,411 | -$1,930 |
| Capital Expenditures | -$246 | -$3,625 | -$2,523 | -$941 |
| Free Cash Flow | -$28,163 | -$47,887 | -$18,934 | -$2,871 |